Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

NCT06573411 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: ACEI/ARB+ finerenone
DRUG: ACEI/ARB

Sponsor

First Affiliated Hospital, Sun Yat-Sen University